{
  "id": "mhgap#general_c393dbd9",
  "content": "Tremor Trembling or shaking movements, usually of the fingers, that is an involuntary\noscillation of a body part.\nValproic acid (sodium See the WHO model list of essential medicines (EML).1 The full medicine name,\nvalproate) “valproic acid (sodium valproate)”, is used in the recommendation text with the\nbriefer term “sodium valproate” used in other sections of the recommendation.\nVitamin K deficiency disease Lack of vitamin K can cause severe bleeding in newborn babies usually\nof the newborn immediately after birth but sometimes up to 6 months of age. Bleeding may\nbe cutaneous, gastrointestinal, intracranial or mucosal. Maternal intake of\nantiseizure medicines is one of its causes.\n1 The current EML (23rd list, 2023) is available at: https://iris.who.int/handle/10665/371090\nxv\nExecutive summary\nBackground and objectives Target audience\nMental, neurological and substance use (MNS) The guideline is targeted towards non-specialized\ndisorders are major contributors to morbidity and health workers at primary- or secondary-level health-\npremature mortality in all regions of the world. The care facilities, or those working at the district level\nresources that have been provided to tackle the huge including basic inpatient and outpatient services.\nburden of MNS disorders are insufficient, inequitably The guideline also targets health workers in general",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "work"
    ],
    "is_clinical": false,
    "is_advice": false
  },
  "index_text": "General — General Tremor Trembling or shaking movements, usually of the fingers, that is an involuntary\noscillation of a body part.\nValproic acid (sodium See the WHO model list of essential medicines (EML).1 The full medicine name,\nvalproate) “valproic acid (sodium valproate)”, is used in the recommendation text with the\nbriefer term “sodium valproate” used in other sections of the recommendation.\nVitamin K deficiency disease Lack of vitamin K can cause severe bleeding in newborn babies usually\nof the newborn immediately after birth but sometimes up to 6 months of age. Bleeding may\nbe cutaneous, gastrointestinal, intracranial or mucosal. Maternal intake of\nantiseizure medicines is one of its causes.\n1 The current EML (23rd list, 2023) is available at: https://iris.who.int/handle/10665/371090\nxv\nExecutive summary\nBackground and objectives Target audience\nMental, neurological and substance use (MNS) The guideline is targeted towards non-specialized\ndisorders are major contributors to morbidity and health workers at primary- or secondary-level health-\npremature mortality in all regions of the world. The care facilities, or those working at the district level\nresources that have been provided to tackle the huge including basic inpatient and outpatient services.\nburden of MNS disorders are insufficient, inequitably The guideline also targets health workers in general Tremor trembling or shaking movements, usually of the fingers, that is an involuntary\noscillation of a body part. valproic acid (sodium see the who model list of essential medicines (eml).1 the full medicine name,\nvalpro..."
}